Pyronaridine
Systematic (IUPAC) name | |
---|---|
4-[(7-Chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol | |
Clinical data | |
Routes of administration | Oral, intramuscular injection, intravenous therapy |
Legal status |
|
Identifiers | |
CAS Number | 74847-35-1 |
ATC code | none |
PubChem | CID 5485198 |
ChemSpider | 10647812 |
UNII | TD3P7Q3SG6 |
ChEMBL | CHEMBL35228 |
Chemical data | |
Formula | C29H32ClN5O2 |
Molar mass | 518.05 g/mol |
| |
| |
(what is this?) (verify) |
Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s.[1]
It is one of the components of the artemisinin combination therapy pyronaridine artesunate (Pyramax).
References
- ↑ Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Trans R Soc Trop Med Hyg 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.